Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PROTEIN MISFOLDING: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PROTEIN MISFOLDING is a concept in neurodegeneration research. Key relationships include: associated with, regulates, activates. Associated with Aging, Als, Alzheimer. Connected to 224 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | PROTEIN MISFOLDING |
| Key Genes/Proteins | AGING, AKT, ALPHA-SYNUCLEIN, ALS, ALZHEIMER, ALZHEIMER'S DISEASE |
| Related Diseases | Aging, Als, Alzheimer, Amyotrophic Lateral Sclerosis |
| Related Pathways | Amyloid |
graph TD
PROTEIN_MISFOLDING["PROTEIN MISFOLDING"]
PROTEIN_MISFOLDING -->|"causes"| Alzheimer_s_disease["Alzheimer's disease"]
PROTEIN_MISFOLDING -->|"causes"| Parkinson_s_disease["Parkinson's disease"]
PROTEIN_MISFOLDING -->|"causes"| Huntington_s_disease["Huntington's disease"]
PROTEIN_MISFOLDING -->|"causes"| cystic_fibrosis["cystic fibrosis"]
PROTEIN_MISFOLDING -->|"causes"| ALS["ALS"]
PROTEIN_MISFOLDING -->|"interacts"| Als["Als"]
PROTEIN_MISFOLDING -->|"regulates"| Ms["Ms"]
PROTEIN_MISFOLDING -->|"inhibits"| Parkinson["Parkinson"]
advanced_glycation_end_product["advanced glycation end products"] -->|"activates"| PROTEIN_MISFOLDING
molecular_chaperones["molecular chaperones"] -.protects against.-> PROTEIN_MISFOLDING
pharmacological_chaperones["pharmacological chaperones"] -.protects against.-> PROTEIN_MISFOLDING
TUDCA["TUDCA"] -.protects against.-> PROTEIN_MISFOLDING
APOPTOSIS["APOPTOSIS"] -->|"causes"| PROTEIN_MISFOLDING
NEURODEGENERATION["NEURODEGENERATION"] -->|"causes"| PROTEIN_MISFOLDING
NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"causes"| PROTEIN_MISFOLDING| Target | Relation | Type | Str |
|---|---|---|---|
| Alzheimer's Disease | drives | disease | 0.95 |
| Neurodegenerative Diseases | causes | disease | 0.95 |
| NEURODEGENERATION | contributes_to | process | 0.95 |
| Neurodegenerative Diseases | contributes_to | disease | 0.95 |
| Neurodegenerative Disease | contributes_to | disease | 0.95 |
| Alzheimer's Disease | contributes_to | disease | 0.91 |
| ALS | associated_with | gene | 0.90 |
| Therapeutic Targets | involved_in | mechanism | 0.90 |
| intercellular transmission | promotes | process | 0.90 |
| alzheimer_disease | contributes_to | disease | 0.90 |
| Amyotrophic Lateral Sclerosis | contributes_to | disease | 0.90 |
| Parkinson's Disease Neurodegeneration | contributes_to | process | 0.90 |
| Motor Neuron Degeneration | contributes_to | phenotype | 0.85 |
| Parkinson's Disease | contributes_to | disease | 0.85 |
| Apoptosis | contributes_to | process | 0.80 |
| Neurodegeneration | activates | disease | 0.75 |
| Als | associated_with | disease | 0.75 |
| Neurodegeneration | biomarker_for | disease | 0.75 |
| Als | activates | disease | 0.75 |
| MITOCHONDRIAL DYSFUNCTION | associated_with | gene | 0.70 |
| Oxidative Stress | activates | pathway | 0.70 |
| ALS | causes | disease | 0.70 |
| Oxidative Stress | associated_with | pathway | 0.70 |
| NEURODEGENERATIVE DISEASES | interacts_with | gene | 0.70 |
| neurodegeneration | promotes | process | 0.70 |
| Alzheimer's disease | causes | disease | 0.70 |
| Parkinson's disease | causes | disease | 0.70 |
| Huntington's disease | causes | disease | 0.70 |
| cystic fibrosis | causes | disease | 0.70 |
| Alzheimer | protects_against | disease | 0.65 |
| Neurodegeneration | protects_against | disease | 0.65 |
| Ataxia | treats | disease | 0.65 |
| Parkinson | treats | disease | 0.65 |
| Aging | treats | disease | 0.65 |
| Dementia | treats | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | biomarker_for | disease | 0.65 |
| Neurodegeneration | inhibits | disease | 0.65 |
| Als | treats | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Huntington | causes | disease | 0.65 |
| Alzheimer | causes | disease | 0.65 |
| Parkinson | causes | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Fibrosis | causes | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Neuroinflammation | inhibits | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | treats | disease | 0.65 |
| Insulin Resistance | inhibits | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ALS | associated_with | disease | 0.95 |
| Alzheimer'S | associated_with | disease | 0.95 |
| Autophagy | involved_in | pathway | 0.95 |
| L444P variant | causes | biomarker | 0.90 |
| C9ORF72 | causes | gene | 0.90 |
| OXIDATIVE STRESS | critical_for | process | 0.90 |
| ALS | causes | disease | 0.90 |
| FUS | causes | gene | 0.90 |
| SOD1 | causes | gene | 0.90 |
| TARDBP | causes | gene | 0.90 |
| Autophagy | inhibits | process | 0.90 |
| Ages | promotes | compound | 0.85 |
| Advanced Glycation End Products | contributes_to | compound | 0.85 |
| Pathological Seeds | biomarker_for | biomarker | 0.85 |
| Autophagy | regulates | pathway | 0.85 |
| ubiquitin-proteasome | mediates | pathway | 0.80 |
| oxidative stress response | mediates | pathway | 0.80 |
| autophagy pathway | mediates | pathway | 0.80 |
| apoptosis pathway | mediates | pathway | 0.70 |
| TAU | inhibits | protein | 0.70 |
| NEURODEGENERATION | biomarker_for | gene | 0.70 |
| advanced glycation end products | activates | process | 0.70 |
| TUDCA | protects_against | drug | 0.70 |
| OXIDATIVE STRESS | associated_with | gene | 0.70 |
| molecular chaperones | protects_against | protein | 0.70 |
| pharmacological chaperones | protects_against | drug | 0.70 |
| FUS | regulates | gene | 0.65 |
| TAU | causes | protein | 0.65 |
| CELL SURVIVAL | protects_against | phenotype | 0.65 |
| TDP-43 | interacts_with | gene | 0.65 |
| ALS | interacts_with | gene | 0.60 |
| CELL SURVIVAL | stabilizes | phenotype | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| ATG3 | associated_with | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | associated_with | gene | 0.60 |
| SQSTM1 | associated_with | gene | 0.60 |
| LC3B | associated_with | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| SCA3 | associated_with | gene | 0.60 |
| NEURODEGENERATION | inhibits | gene | 0.60 |
| INSULIN RESISTANCE | inhibits | gene | 0.60 |
| OXIDATIVE STRESS | inhibits | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | activates | gene | 0.60 |
| ALS | contributes_to | gene | 0.60 |
| SOD1 | activates | gene | 0.60 |
| NEUROINFLAMMATION | activates | gene | 0.60 |
| TNF-Α | activates | gene | 0.60 |
| HUNTINGTON | activates | gene | 0.60 |
| PROINFLAMMATORY CYTOKINES | activates | gene | 0.60 |
| IL-6 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning PROTEIN MISFOLDING in their description or question text
No additional research found